A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Stimwave and Nevro Reach Settlement In Patent Infringement Lawsuit

Stimwave Agrees to a Permanent Injunction in Exchange for Dismissal of Lawsuit with No Damages Assessed

For its spinal cord stimulation products only, Stimwave Technologies has agreed to a permanent injunction such that Stimwave’s spinal cord stimulation products will not deliver any therapy that includes pulse frequencies between 1,500 Hz and 100,000 Hz.

Paul LaViolette, Stimwave’s chairman and interim CEO, said, “The new management team at Stimwave is pleased to put this litigation from past management behind us. We will continue to focus commercialization on the tiny form factor of our Freedom neurostimulators, which can be used throughout the body, eliminate the need for large internal batteries, and are fully MRI compatible.” He concluded, “Those attributes are the key to our products’ consistent double-digit annual growth and potential to disrupt both the spinal cord and peripheral nerve neuromodulation market.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy